Axsome Therapeutics Inc (AXSM) earnings · rev $638.5M
These earnings events as JSON? API free 100/dayAxsome Therapeutics Inc (AXSM) is a biotechnology company listed on US.
This AXSM earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported AXSM revenue for 2025-12-31 was $638.5M. Net income was -$183.2M. Revenue was up 65.5% from 2024-12-31 to 2025-12-31. AXSM currently screens at market cap $11.96B.
When the next AXSM 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 65.5% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full AXSM research stays on the stock page; the tape stays on the quote page.
AXSM earnings FAQ
What are AXSM's latest revenue and net income?
Latest cached Axsome Therapeutics Inc (AXSM) revenue for Dec 31, 2025 was $638.5M. Net income was -$183.2M. Statements: https://lician.com/financials/axsm
What is AXSM's latest diluted EPS?
Latest cached Axsome Therapeutics Inc (AXSM) diluted EPS for Dec 31, 2025 was -$3.68.
What period does the latest AXSM earnings print cover?
The latest cached Axsome Therapeutics Inc (AXSM) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did AXSM revenue change from the prior cached period?
Cached Axsome Therapeutics Inc (AXSM) revenue was up 65.5% from $385.7M (Dec 31, 2024) to $638.5M (Dec 31, 2025). Statements: https://lician.com/financials/axsm
Where are AXSM earnings listed?
Cached earnings facts for Axsome Therapeutics Inc (AXSM) are listed at https://lician.com/earnings/axsm. Statements: https://lician.com/financials/axsm
Not investment advice.